Lupin gets USFDA nod for Pioglitazone Hydrochloride Tablets

09 Apr 2014 Evaluate

Pharma Major Lupin has received US Food and Drug Administration (US FDA) nod for Pioglitazone Hydrochloride Tablets. Pioglitazone tablets are to treat high blood sugar associated with diabetes.

Earlier in March, the company received final approval for its Doxycycline Capsules USP, 50 mg, 75 mg, and 100 mg from the United States Food and Drugs Administration (US FDA) to market a generic version of Aqua Pharmaceuticals' Monodox Capsules 50 mg, 75 mg, and 100 mg.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

 

Lupin Share Price

2121.65 -25.95 (-1.21%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×